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Abstract
In recent years microRNAs have become recognized as pervasive, versatile agents of gene regulation.
Some widely embraced rules involving Watson-Crick hybridization of microRNAs with mRNAs
have generated great interest as scientists envision potential RNA cargoes for gene therapy and other
experimental systems. However, while researchers ardently seek simplifying principles, nature seems
very uncooperative. This article reviews some small RNA mechanisms that potentially regulate genes
and which are not covered by previous microRNAs characterizations. In addition, we report here
results of fluorescence microscopy experiments to directly demonstrate nuclear importation of small
RNAs equal in length to typical mature microRNAs, implying that gene regulation at the locus of
transcription might be possible.
1. Introduction
“When we add to the truth, we subtract from it.” This saying, attributed to the Talmud, is
certainly exemplified by microRNA (miRNA) research. For the present and foreseeable future,
the arrival rate of new miRNA phenomena and layers of complexity exceeds and will exceed
the departure rate of solved problems.
Current research points to miRNA roles in the general management and fine-scale control of
protein synthesis (Baek et al., 2008; Selbach et al., 2008), with implications regarding cancer
(Lujambio et al., 2008), immune response (Stern-Ginossar et al., 2008), viral immunoevasion
(Umbach et al., 2008), apoptosis (Yamakuchi et al., 2008), cell cycle control (Cloonan et al.,
2008; Chivukula and Mendell, 2008), and stem cell differentiation (Li Z et al., 2008). Gene
management by miRNAs and other noncoding RNAs can employ alteration of transcription
rates, RNA stability, translational efficiency, and methylation of chromatin. Furthermore,
proteins can return the favor by controlling miRNA biogenesis (Chang et al., 2007), suggesting
a vast world of complex gene expression regulation suitable for anyone seeking a really hard
network control problem.
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miRNA gene regulation is conventionally regarded as targeting 3′ untranslated regions (3′
UTRs) of mRNAs and inhibiting gene expression. However, a recent report (Tay et al.,
2008) identifies targets occurring throughout some mRNAs; in particular, mouse transcription
factors Nanog, Pou5f1 (formerly called Oct4) and Sox2 display many naturally occurring
miRNA targets in their amino acid coding sequences. The seed region of an miRNA is defined
as the sequence of nucleotides in positions 2 through 8 from the 5′ terminus. Popular web
engines use bioinformatic complementarity of the seed with 3′UTRs and additional rules such
as conservation to provide a first approximation of miRNA-mRNA targeting. However, some
experimentally verified targets (Tay et al., 2008) do not contain the miRNA seed, some span
exon-exon junctions, and some are not conserved across human and rhesus genomes.
miRNAs are generally considered post-transcriptional inhibitors of translation or accelerants
of mRNA degradation, that is, downregulators of gene expression. However, recent reports
(Li et al., 2006; Janowski et al., 2007; Place et al., 2008) have further increased the potential
complexity of miRNA regulation by describing instances in which miRNAs or transfected
double-stranded RNAs (dsRNAs) designed as if they were short interfering RNAs (siRNAs)
can upregulate gene expression. Evidently several genes–genes intensively studied in other
contexts–can be upregulated by siRNA targeting of their promoter regions. This means
targeting chromosomal dsDNA in the nucleus, using target selection algorithms designed for
ssRNA messages in the cytoplasm. Puzzles implied by the observations of upregulation include:
1. Given that the effects are actually on transcription (Janowski et al., 2007), how is
ectopic siRNA (dsRNA with TT 3′overhangs) imported into the nucleus?
2. To what degree is nuclear import of RNA sequence-specific?
3. Into what form is ectopic dsRNA processed or complexed in order to interact with a
chromosomal promoter region?
4. Does promoter dsDNA somehow open and hybridize sequence-specifically with
imported ssRNA?
5. How can observed shifting by only a few bases change activation into deactivation,
or change a strong effect such as 18-fold upregulation into no effect (Janowski et al.,
2006)?
6. If cryptic noncoding antisense transcripts from promoter regions are the actual targets
(as suggested by Schwartz et al. (2008)), then what function do they have in routine
gene expression?
7. Do endogenous miRNAs or siRNAs exist that target promoter regions and upregulate
transcription?
The purpose of this paper is to provide some background information that might support
resolution of the puzzles.
2. Materials and methods
2.1. RNAi mechanisms
Experimentally manipulated, conventional RNA interference (RNAi) is synthetic, sequence-
specific suppression of gene expression by introduction of double-stranded RNAs (dsRNAs)
into cells. Introduction means the RNA is treated in some way to allow passage through the
cell membrane and into the cytoplasm, and interference usually means accelerated degradation
or translational inhibition of a specific mRNA. In RNAi of human cells, the dsRNA is then
processed by DICER ribonuclease into small interfering RNAs (siRNAs) which are complexed
with argonaute (Ago) proteins, forming an RNA induced silencing complex (RISC). The RISC-
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associated siRNA can hybridize with a complementary section of an mRNA message, causing
argonaute-mediated cleavage of the mRNA or otherwise interfering with translation. There are
multiple variations on the siRNA theme with modified nucleic acids and other chemical
modifications to enhance stability, selectivity, and specificity, as well as reduce toxicity.
Alternatively, when the antisense strand of the siRNA is somehow imported into the nucleus,
it can target chromatin of a specific promoter region (Morris KV, 2008). Such siRNA causes
epigenetic revision of local histone code and chromatin marks, leading to heterochromatization
of the targeted gene. As pointed out by Morris, epigenetic modifications could be much more
persistent that conventional siRNA targeting mRNAs.
Several web-based engines, some with proprietary algorithms, are available for selection of
optimal siRNA targets within an mRNA sequence for custom RNAi. Alternatively, several
vendors guarantee effectiveness of their stock or made-to-order siRNA products. A guarantee
means generally that some fraction such as two-thirds of products purchased are effective, and
effectiveness means downregulation of mRNA by at least a certain fraction such as 50%.
Regarding the usefulness of the algorithms, it should be noted that random siRNA targeting
also has significant impact on gene expression in about half of tries, but typically, design and
synthesis in a lab would start with comparison of several algorithm outputs. Eventually,
successful trials of siRNA pharmaceuticals will require that siRNA treatments strongly
downregulate targeted genes (selectivity) and only do so in targeted cells (specificity)
(Krützfeldt et al., 2005; Kumar et al., 2008). There is already a rich literature on siRNA drug
design dealing with these notions.
Regarding transcriptional silencing (so RNAi in the nucleus applied to chromosomal dsDNA),
Weinberg et al. (2006) measured histone methylation at targeted promoters. They reported that
siRNA treatment by the antisense strand alone can increase both H3K9 and H3K27 methylation
of the promoter of a targeted gene, EF1A, and that this increase is dependent on nuclear specific
delivery of the siRNA.
Janowski et al. (2006) showed that AGO1 and AGO2 connect pathways for mRNA silencing
with pathways for recognition of chromosomal DNA. Complements to transcription start sites
or upstream regions in gene promoters called synthetic antigene RNAs (agRNAs) inhibited
gene transcription. Such silencing occurs in the nucleus, requires high promoter activity, and
does not necessarily require histone modification. The researchers reported that AGO1 and
AGO2 proteins associated with promoter DNA in cells treated with agRNAs, and that inhibiting
expression of AGO1 or AGO2 reversed transcriptional and post-transcriptional silencing. Their
data indicated key linkages and important mechanistic distinctions between transcriptional and
post-transcriptional silencing pathways in mammalian cells.
2.2 Sources of endogenous dsRNAs
Aside from pre-miRNAs, there might be many additional sources of RNA hairpins that
contribute to gene regulation. Pervasive transcription of human and mouse genomes
(Katayama, 2005; ENCODE, 2007) yields a potentially huge supply of noncoding RNAs,
including dsRNAs that could enter the miRNA pathway to emerge both as mRNA inhibitors
and as activators of promoters. Inverted repeat structures, bidirectional transcription, and
antisense transcripts from various loci are sources of dsRNAs. Okamura and Lai (2008) have
reviewed recent research regarding endo-siRNA, meaning processing of diverse hairpins (other
than pre-miRNAs) that do not generally conform to pre-miRNA sequence statistics (Zhang et
al., 2006). The stems could become RISC-mounted exact complements of mRNAs, promoting
cleavage. In particular, such endo-siRNA may be responsible for control of transposable
element transcripts in mouse oocytes (Puschendorf et al., 2006; Tam et al., 2008). That is,
transposon-derived hairpin sequence elements may contribute to the metabolism of mouse
maternal transcripts through a Dicer-dependent pathway. Thus RNAi triggered by antisense
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transcripts may modulate human L1 retrotransposition efficiently and economically (Yang and
Kazazian, 2006). Naturally occurring dsRNAs might also regulate protein-coding transcripts
(Watanabe et al., 2008).
It has been hypothesized (Jeffries, 2006) that large, well-formed hairpins from intronic Alu
sequences adjacent to their complements could serve as substrates to produce multiple siRNA
fragments. Processing through an miRNA pathway could yield cleavage or translational
inhibition of mRNAs having Alu sequences in their UTRs or introns. Such Alu hairpins
hypothetically could be produced from a large number of introns. For example, the gene
encoding pro-apoptotic PAWR could generate such byproduct hairpins from three loci in one
of its introns, leading to downregulation of genes such as anti-apoptotic BACL4 with a 3′UTR
Alu. In this manner, initiation of apoptosis could automatically inhibit anti-apoptosis response
in a cell. In fact, a naturally occurring, miRNA instance of this type of feed forward control
has been reported (Barik, 2008) for AATK, a gene essential for promoting neuronal
differentiation. Transcription of AATK yields miR-338 as an intronic byproduct, and miR-338
silences a family of genes that are negative regulators of neuronal differentiation.
However, only a small subset of hypothetical hairpins might be selected for siRNA production,
since long dsRNAs (Stein et al., 2005) in mammalian cells induce an antiviral response
mediated by interferon (IFN) that leads to general inhibition of protein synthesis and
nonspecific degradation of mRNAs.
2.3 Nuclear import
That miRNAs might be naturally imported into HeLa nuclei was suggested by Hwang et al.
(2007). They observed that miR-29b, tagged with a fluorophore, localized in HeLa nuclei.
Experiments included using confocal microscopy (so that images are virtual sections that show
what is in, not on, nuclei). Hwang et al. found that other small ssRNAs when modified to
include AGUGUU at 3′ terminus also entered the nucleus. The same authors later submitted a
patent application (Hwang et al., patent application, 2007) covering the pattern AGUGUU and
seven other nucleotide (nt) patterns (UGUGUU, ACUGUU, AGAGUU, AGUCUU,
AGUGAU, AGUGUA, AGNGUN) as distinguished sequences for enabling nuclear import.
They demonstrated as well that several similar sequences were not imported. However, the
complexity of nuclear import mechanisms might not be consistent with such a concise list.
The mechanism of nuclear import of miR-29b is unknown. Possibly AGUGUU is an RNA
sequence that binds sequence-specifically to a protein already subject to nuclear import. Clues
include a report by Guang et al (2008) on factors essential for RNA interference (RNAi) in
nuclei of Caenorhabditis elegans. A cytoplasmic Argonaute protein NRDE-3 with a bipartite
nuclear localization sequence (NLS) binds exclusively to endogenous siRNAs generated from
mRNA templates; binding of siRNAs to NRDE-3 is required to promote relocation of NRDE-3
from the cytoplasm to the nucleus. In mutant worms defective in endogenous siRNA
production, NRDE-3 becomes associated with exogenous siRNAs, suggesting a mechanism
adaptable to various RNA sequences. The NRDE-3 associated RNA is recruited by importin
proteins and conveyed via the nuclear pore complex to and into the nucleus where the RNA
might associate with nascent transcripts.
2.4 Extraordinary extensions of known siRNA and miRNA capabilities
Li LC et al. (2006) reported that 21 nt dsRNA (with 3′ overhang = TT) targeted (exact match)
to sequences selected by conventional siRNA algorithms could have the effect of
upregulation of CDH1 (alias E-cadherin) gene expression. The effect was discerned down to
application of ~5 nM. Indeed, the intersection of outputs of several public, web-based siRNA
target selection algorithms includes the specified region. Upregulation was AGO2-dependent
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and did not induce an IFN response. dsRNAs targeting nearby regions instead resulted in slight
downregulation, indicating the effect is sequence specific. Shortening the dsRNA to 16 nt or
extending it to 26 nt also abrogated enhanced expression. The researchers noted that while
RNAi by siRNA transfection typically lasts 5–7 days, observed enhancement persisted for
more than 10 days. Chromatin immunoprecipitation analysis revealed epigenetic changes that
might be inheritable through mitosis, providing a possible explanation for persistence.
Also studied by Li LC et al. (2006) with similar results were genes CDKN1A (alias p21WAF1/
CIP1) and VEGF. Increases from 2- to 10-fold in mRNA and protein levels were variously
detected. However, tests with genes ATR, PTEN, and APC did not produce strong
upregulation. It would be of interest to understand this difference in susceptibility to
upregulation.
In a subsequent paper (Place et al., 2008) by researchers also affiliated with the Dahiya lab,
gene promoters were scanned for sequences complementary to known miRNAs seeds. An
miR-373-3p target site was predicted in the promoter of CDH1. Transfection of miR-373-3p
and its pre-miRNA into a human prostate cancer cell line induced CDH1 expression (but
slightly mutated sequences did not) in a DICER-dependent manner and concomitant with
enrichment of Pol II at the promoter. The miR-373-3p target site is further upstream from the
siRNA target used by Li LC et al. (2006) and near the 5′ end of an Alu with + orientation. In
Fig 1 the seed target is AGCACTT within the blue boundary:
The significance of location in an Alu is that so many Alus appear in gene promoters, suggesting
vast potential for analogous effects on other genes. Searching ~14,000 human promoter regions
(up to 5000 bases upstream of transcription start) has revealed heavy Alu enrichment (Polak
and Domany, 2006). The distribution is highly dependent upon gene function. For example,
Alus are dense in promoters of RNA processing genes (about 5 Alus per 5 kb region) and
relatively sparse in CNS development genes (about 2 per 5 kb, which is close to random
distribution of one million Alus). Furthermore, several miRNAs are similar to miR-373 and
might share targets, including miR-20a,b, -93, -17-5p, -106a,b, -372, -302a,b,c,d (Smalheiser
and Torvik, 2006). Presumably almost all of the putative interactions are not in effect due to
epigenetic or other factors, but it would be strange if miR-373 upregulation of CDH1 were the
only case in nature.
The Corey lab has also done much to substantiate the case for upregulation by siRNAs and
miRNAs (Janowski et al., 2007). They reported identification of multiple duplex RNAs
complementary to the promoter of PR (progesterone receptor) that increase expression of PR
mRNA and protein after transfection into cultured T47D or MCF7 human breast cancer cells.
The dsRNA or ssRNA sequences that induced upregulation of PR included a 19 nt exact
complement to a target sequence in the PR promoter plus a TT tail. Upregulation of PR was
discovered by growing T47D cells in serum-stripped medium lacking hormones, thus having
reduced expression of PR. Adding a particular dsRNA rescued normal PR expression. The
researchers wrote, “It is possible that the activating RNAs bind directly to DNA, but is also
possible that they bind to rare RNA transcripts that initiate upstream from the TSS
[transcription start site] or bind to antisense transcripts; our data are consistent with either
mechanism.” Interestingly, shifting the target sequence only two nts nullified the effect in some
instances. In a follow-up study, the same lab showed that, indeed, the actual targets for
“promoter-directed” siRNAs which either increased or decreased PR transcription are
antisense transcripts initiating elsewhere but overlapping the PR transcription unit (Schwartz
2008). The siRNAs affecting transcription were dubbed “antigene RNAs” (agRNAs). Their
ability to affect gene expression requires Argonaute proteins which target the agRNAs to the
antisense transcript. The AGO-agRNA-antisense RNA complex then recruits other factors,
such as hnRNP-k and heterochromatin protein 1, that then alter gene expression.
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As another instance of miRNA upregulation of translation, Vasudevan et al. (2007) and
Vasudevan et al. (2008) connected cell cycle phases with regulatory effects. They showed in
HEK293 cells (Human Embryonic Kidney) that miRNAs including let-7 induced translation
downregulation of target mRNAs in proliferating cells but upregulation in quiescent cells. They
suggested that miRNAs generally have the potential to regulate translation in a manner
determined by cell cycle phase.
Cloonen et al. (2008) studied the cluster of miRNAs known as miR-17-92 (Woods et al.,
2007). They found it to be a cell cycle regulated locus. Ectopic expression of a member miRNA
(miR-17-5p) was sufficient to drive a proliferative signal in HEK cells in a mechanism acting
specifically at the G1/S cell cycle boundary when pro-proliferative mRNAs were upregulated
through secondary effects. Thus the connection of cell cycle with miRNA signals includes a
network of direct and indirect, up- and downregulation effects.
3. Results
3.1 Additional study of AGUGUU
Returning to the important observations of Hwang et al. (2007) on AGUGUU, our own
investigation revealed the following. miRNAs miR-29b and miR-29a are defined as
miR-29b 5 -UAGCACCAUUUGAAAUCAGUGUU-3 
miR-29a 5 -UAGCACCAUCUGAAAUCGGUU -3 
For mitotic HeLa cells, Hwang et al. (2007) found using northern blots that the nuclear/
cytoplasmic distribution of miR-29b was 71/29 while that of miR-29a was 42/58. Confocal
microscopy results with fluorophore-tagged 29a and 29b siRNAs showed a localization
consistent with the endogenous miR-29 RNAs. In additional tests with synthetic siRNAs,
sequences ending in AGUGUU were found to have the strongest nuclear concentrations. Thus
the researchers concluded, “These RNAs may prove useful for the manipulation of nuclear
steps in gene expression,” a belief reflected in their patent activities.
We transfected into HeLa cells selected RNA sequences tagged with fluorescein (FAM).
Transfection employed the DeliverX protocol (Panomics, Fremont CA) using a short
amphipathic peptide that forms stable nanoparticles with nucleic acids that enter cells
independent of endosomal pathways (Morris MC et al., 2008). Small ssRNA species were
obtained from IDT (Coralville IA).
We first applied tagged sequences equal to or derived from the miR-29b sequence; the derived
sequence had AGUGUU omitted from the 3′ terminus. Results are shown in Fig 2.
Next we treated human neural progenitors derived from olfactory epithelium. The agent was
not so readily transfected, but nuclear penetration of agent with AGUGUU was observed as
shown in Fig 3.
We also reviewed the discoveries of Place et al. (2008) on miR-373. Fig 4 shows the predicted
structure of the pre-miRNA; miR-373-5p is in the blue boundary and miR-373-3p is in the red.
Underlined is subsequence AGUGCUU, suggesting a relationship with the AGUGUU
sequence studied above.
Again transfection of agents was used to study nuclear import. The two agents were FAM
+adenine+mature miR-373-5p versus FAM+miR-373-3p mature. Results are shown in Fig 5.
Interestingly the agent with AGUGCUU penetrated some nuclei while the -5p agent did not.
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We have suggested or described several speculative miRNA mechanisms for which recent
evidence exists. Clearly there is much to keep miRNA researchers busy. We note that our own
evidence is based upon confocal microscopy, but care should be taken in interpretation since
identical cells in the one experiment are capable of very nonidentical, stochastic phenomena
(Raj and van Oudenaarden, 2008). Nuclear assays are needed that corroborate and investigate
putative nuclear miRNA import mechanisms such as the possible connection suggested in Fig
4 between AGUGUU in miR-29b (Hwang et al., 2007) and AGUGCUU in miR-373-3p (Place
et al., 2008). Much additional work is needed to clarify nuclear import mechanisms for small
ssRNAs..
However, a diagram that organizes the potential interactions and flows is shown in Fig 6. While
a number of nuclear roles for mi- and siRNAs have been reported, so far only human Ago2
and C. elegans NRDE-3, both members of the Argonaute family of RNA-binding proteins,
have been found responsible for RNA nuclear localization (Guang 2008,Ohrt 2008). However,
it is unknown how these proteins with their bound RNAs are imported. AGO2 might or might
not be related to the up- or downregulation phenomena involving promoter regions described
above.
Strategies exist for advancement against the bewildering complexity of miRNA mechanics. A
good example is that of Fedorov and Karpilow (2008), who have addressed the question: what
miRNAs and proteins determine differentiation lineages of stem cells? Suppose a phenotypic
outcome is detected. A screen strategy described in their technical note employs transfection
in a propagation medium with a library of miRNA inhibitors followed by substitution with
differentiation medium and phenotype monitoring. The same is done with a matched library
of miRNA mimics. Transfection hits are selected on the basis of dosage dependency and
induction of opposite effects from inhibitor and mimic pairs. Then a bioinformatic search
interrogates 3′UTR tables for logically related genes. It might be advisable to apply loose
versions of targeting algorithms that allow a single gap on one side in the seed region. Finally,
a rescue strategy for implicated miRNA-protein pairs enforces inhibition of the miRNA, then
checks for loss of phenotype, then inducts an exogenous protein source, and finally checks for
rescue of phenotype. Many variations on such strategies become possible. In the particular case
of mesenchymal stem cell osteogenesis studied by Fedorov and Karpilow, the outcome was
selection of just three miRNAs; interestingly, two have very similar seed regions (hsa-miR-489
= GUGACAUCACA... and hsa-miR-148b = UCAGUGCAUCACA...), suggesting closely
related targeting. Thus there are examples in which careful experimental design, modern
screening products, and judicious use of bioinformatics enable researchers to bridge the
yawning gap between what they know and what they would like to know.
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How miR-373-3p might hybridize with a hypothetical transcript from an Alu repeat in the
promoter of CDH1. The seed region is within the blue boundary.
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Agent with AGUGUU penetrated some HeLa nuclei while agent without did not. Images A,D
are DIC micrographs with bar = 10 um; images B,E are FAM emission confocal micrographs;
images C,F are DRAQ5™ emission confocal micrographs. Cells in the upper three images were
transfected with FAM+UAGCACCAUUUGAAAUC; no nuclei have FAM fluorescence.
Cells in the lower three images were transfected with FAM
+UAGCACCAUUUGAAAUCAGAGUU; most nuclei have at least some FAM fluorescence
(blue arrows). Here and also in Figs 3 and 5 the brightness and contrast settings for each
fluorescence channel are identical. The confocal images are from a ~400 nm slice of the sample.
Cells were alive. The images were obtained 3 to 4 hours post-treatment, hence nuclear import
was not always related to a particular cell cycle phase, including the mitosis phase. Scale bar
= 10 μm.
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Agent with AGUGUU penetrated some olfactory epithelium neural progenitor nuclei while
agent without did not. Images A,D are DIC micrographs with bar = 10 um; images B,E are
FAM emission confocal micrographs; images C,F are DRAQ5™ emission confocal
micrographs. Cells in the upper three images were transfected with FAM
+UAGCACCAUUUGAAAUC; nuclei have no FAM fluorescence, even at high excitation
power. The cell in the lower three images was transfected with FAM
+UAGCACCAUUUGAAAUCAGAGUU and has some FAM fluorescence (blue arrows)
from its nucleus.
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The two miRNAs from the pre-miR-373 hairpin. The observation of miR-373 regulatory
activity by Place et al, (2008) might be due to the inclusion of AGUGCUU, as it is similar to
the sequence AGUGUU associated with nuclear import by Hwang et al. (2007).
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Agent with miR-373-3p penetrated ~10% HeLa nuclei while agent with miR-373-5p penetrated
none in our observations. Images A,D are DIC micrographs with bar = 10 um; images B,E are
FAM emission confocal micrographs; images C,F are DRAQ5™ emission confocal
micrographs. Cells in the upper three images were transfected with FAM
+UAGCACCAUUUGAAAUC; no nuclei have FAM fluorescence. Cells in the lower three
images were transfected with FAM+UAGCACCAUUUGAAAUCAGAGUU; most nuclei
have at least some FAM fluorescence (blue arrows).
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Mechanisms, largely speculative or surmised, suggested in this paper. A primary miRNA
transcript (pri-miRNA), possibly from an intron, is chaperoned into folded RNA (purple) by
heterogeneous ribonucleoprotein particles (hnRNPs) (light blue), countering RNA
degradation mechanisms. Possibly a large complex (Gregory et al., 2004) (yellow) or a
sequential or geometric recognition motif (black) guide recruitment of protein products of
genes DGCR8 and RNASEN, yielding excision of a precursor RNA hairpin (pre-miRNA)
(orange with blue subsequence that becomes the mature miRNA). The pre-miRNA is
exported. Protein product of the DICER gene selects an ssRNA section of the hairpin stem,
the mature miRNA, for mounting on an RNA induced silencing complex (RISC) (red).
Evidence exits (Ohrt et al., 2008) that a single protein product of AGO2 enables re-import of
some miRNAs or other short ssRNAs, possibly as a “mini-RISC.” Back in the nucleus the
miRNA might engage open genomic DNA (green) or some cryptic noncoding RNA to enhance
or suppress recruitment of transcription complex to the transcription start site (TSS) of a gene.
Recruitment of agents of chromatin remodeling could be part of the mechanisms.
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